50.1 F
New York
Saturday, April 10, 2021

Biofrontera [NASDAQ: BFRA] Announces Submission of Application for New BF-RhodoLED

Must read

Cameco [NYSE: CCJ] Plans to Restart Cigar Lake Uranium Mine

Cameco Corporation declared that it has decided to resume the cigar lake uranium mine. The firm is intending to restart production in the...

Lucira [NASDAQ: LHDX] COVID-19 Test Kit Reactive to 99.9% of COVID-19 Strains

Lucira Health, Inc. shares skyrocketed more than 18% during the pre-market trading session of Friday after the firm disclosed that its all-in-one COVID-19...

Johnson Control [NYSE: JCI] Buys Silent-Aire

Johnson Controls International Plc disclosed Friday that it has bought Silent-Aire. The deal has valued Silent-Aire at up to $870 million. It also...

Teva [NYSE: TEVA] Gets EU Authorization for Seffalair and BroPair Spiromax

Teva Pharmaceutical Industries Limited disclosed that it has got EU Marketing Authorization for Seffalair Spiromax and its duplicate BroPair Spiromax. This is the...

Biofrontera AG [NASDAQ: BFRA] has disclosed that it has submitted an application for New BF-RhodoLED to FDA. The firm is seeking permission for the use of the BF-RhodoLED XL in combination with Ameluz from the FDA. The combination will be used for the cure of minor and reasonable actinic keratoses on the face and scalp.

This is consistent with the current authorization of Ameluz. The intention is to expand the label to include extra indications in the future. The new PDT lamp allows the cure of larger areas as well as the synchronized coverage of several actinic keratoses distant from each other.

The regulatory submission is unbiased of the change in product information presented to the FDA in February. It was presented to permit the use of three tubes of Ameluz per cure but adds it to cure larger areas. Presently, the product data and thus repayment is restricted to the use of one tube of Ameluz per cure.

The new lamp is protected by several patents before submission to the FDA. The cure settings of the new BF-RhodoLED, such as light dose, and wavelength of light are similar to the BF-RhodoLED.

More articles

Latest article

Amyris [NASDAQ: AMRS] Declares Pricing of Public Offering of Common Stock

Amyris, Inc.  declared that it has commenced the proposed underwritten public offering of shares of its common stock. It has disclosed that is...

Nokia [NYSE: NOK] Roll Out Innovative Cloud Charging Solution on AWS for CSPs

Nokia Corporation has rolled out a cloud-native convergent charging solution on Amazon Web Services (AWS) to speed up communications service providers (CSPs) migration...

Niu Technologies [NASDAQ: NIU] Shares Q1 E-Scooter Sales Volume Results

Niu Technologies has reported the e-scooter sales volume-outcome for the Q1 2021 and update on new products unveiling. The firm disclosed that the...

GameStop [NYSE: GME] is Plunging Today. Here’s Why

Shares of GameStop Corp. is plunging during the pre-market trading session of Monday. The firm’s shares tumbled -16.08% as it lost -30.80 during...

Ceragon [NASDAQ: CRNT] Chosen by TIM Brazil to Take Part in TIP 5G OpenRAN Trials

Ceragon Networks Ltd. disclosed that TIM Brazil has chosen the firm to take part in TIP OpenRAN Trials. After the selection, CRNT will...

Alphabet’s [NASDAQ: GOOGL] Waymo CEO Resign from His Position

Alphabet Inc. has disclosed that the CEO of its subsidiary Waymo has resigned from his position as the CEO of the self-driving startup....

Tesla [NASDAQ: TSLA] Announces First Quarter Vehicle Production & Deliveries Results

Tesla Inc. has reported Friday the details of vehicles it has produced and delivered during the first quarter of 2021. The firm has...

XPeng [NYSE: XPEV] Reports March and First Quarter 2021 Vehicle Delivery Result

XPeng Inc. has disclosed the vehicle delivery results for the month of March and the first quarter of 2021. XPEV revealed that it...